AstriVax, an innovative vaccine platform company, establishes scientific advisory board with world renowned leaders in vaccine development

Post by: Diane De wyngaert in Astrivax Press Release
• Emmanuel Hanon, PhD, will…
read more
26 Sep 2022
0

Coave Therapeutics to Collaborate with World-Renowned Institute of Neurodegenerative Diseases of Bordeaux to Develop Gene Therapy Programs Targeting Protein Degradation in Neurodegenerative Disorders

Post by: Diane De wyngaert in Coave Press Release
Coave Therapeutics to Collaborate with…
read more
20 Sep 2022
0

Minoryx‘s Marketing Authorization Application for its lead candidate leriglitazone validated by EMA for orphan indication X-linked Adrenoleukodystrophy (X-ALD

Post by: Diane De wyngaert in Minoryx Press Release
Minoryx‘s Marketing Authorization Application for…
read more
20 Sep 2022
0

KU Leuven spin-off AstriVax raises € 30 million to build vaccine platform

Post by: Diane De wyngaert in Astrivax
KU Leuven spin-off AstriVax raises…
read more
25 Aug 2022
0

Immunic Receives Notice of Allowance for Composition-of-Matter Patent in the United States for IMU-856, a Small Molecule Modulator Targeting Restoration of Intestinal Barrier Function and Regeneration of Bowel Epithelium

Post by: Diane De wyngaert in Immunic Press Release
Immunic Receives Notice of Allowance for Composition-of-Matter Patent in the United States…
read more
17 Aug 2022
0

Cardior Announces First Patient Dosed in Phase 2 Study Evaluating Efficacy and Safety of Non-coding RNABased Lead Candidate CDR132L in Heart Failure Patients PostMyocardial Infarction

Post by: Diane De wyngaert in Cardior Press Release
Cardior Announces First Patient Dosed…
read more
27 Jul 2022
0

Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Maria Törnsén

Post by: Diane De wyngaert in Immunic Press Release
Immunic, Inc. Strengthens Its Board…
read more
07 Jul 2022
0

Minoryx raises €51 million to support Marketing Authorization Application and launch preparations for X-linked Adrenoleukodystrophy (X-ALD) therapy

Post by: Diane De wyngaert in Minoryx Press Release
Minoryx raises €51 million to…
read more
31 May 2022
0

Immunic Announces Start of Patient Cohorts in Its Phase 1 Clinical Trial of IMU-856 in Celiac Disease

Post by: Diane De wyngaert in Immunic Press Release
Immunic Announces Start of Patient…
read more
05 May 2022
0

Tubulis Closes €60 Million Series B Financing to Accelerate its ADC Pipeline and Expand its Breadth of Platform Technologies

Post by: Diane De wyngaert in Press Release Tubulis
Tubulis Closes €60 Million Series…
read more
03 May 2022
0